Location History:
- Tutzing, DE (2003)
- Munich, DE (2007 - 2010)
Company Filing History:
Years Active: 2003-2010
Title: Innovations and Contributions of Inventor Heinz Bodenmueller
Introduction
Heinz Bodenmueller is a distinguished inventor based in Munich, Germany, recognized for his significant contributions to the field of medical diagnostics. With a total of three patents to his name, he has made substantial advancements particularly in the determination of apoptotic products in patients undergoing therapy.
Latest Patents
Bodenmueller's latest patents focus on innovative methods for assessing the effectiveness of therapies in tumor patients. His first notable invention, "Determination of apoptotic products in tumor patients undergoing therapy," encompasses a method for determining the concentration of apoptotic products in patient samples. This correlation aids in evaluating therapy effectiveness, providing crucial follow-up guidance. Specifically, it emphasizes the determination of nucleosomes in serum samples from tumor patients, enabling healthcare providers to measure the success of tumor therapies, including radiotherapy and chemotherapy treatments.
Another patent by Bodenmueller on the "Detection of apoptotic products" mirrors his first, reinforcing the relevance and applicability of his methods. It highlights the effectiveness of therapy for tumor patients subjected to various treatments and for those recovering from acute ischemic events or hypothermia treatment.
Career Highlights
Heinz Bodenmueller has built his career at Roche Diagnostics GmbH, where he has leveraged his expertise in medical innovation. His work is pivotal in enhancing diagnostic methods that ultimately aim to improve patient outcomes. His dedication to advancing medical science is evident through his patented inventions which have the potential to change how therapy effectiveness is monitored in clinical settings.
Collaborations
Throughout his career, Bodenmueller has collaborated with esteemed professionals in his field, including colleagues such as Stefan Holdenrieder and Martin Busch. These collaborations reflect a commitment to advancing research and developing innovative solutions in the diagnostics landscape.
Conclusion
In summary, Heinz Bodenmueller is a pivotal figure in medical innovation, with a focus on the determination of apoptotic products that can significantly enhance therapy monitoring for tumor patients. His contributions at Roche Diagnostics GmbH and his collaborations with other experts showcase his dedication to improving healthcare through inventive medical diagnostics.